Product
Bevacizumab + Triamcinolone
1 clinical trial
2 indications
Indication
Macular EdemaIndication
Central Retinal Vein OcclusionClinical trial
Combined Treatment of Intravitreous Bevacizumab and Triamcinolone for the Treatment or Macular Edema Secondary to Central Retinal Vein OcclusionStatus: Terminated, Estimated PCD: 2007-06-01